Placeholder Banner

EU’s Anti-Science Comitology Reform Threatens Innovation

February 14, 2017

The Biotechnology Innovation Organization (BIO) issues the following statement in response: 

“BIO is extremely discouraged by the European Commission’s new proposal to alter voting procedures regarding product authorizations, such as import authorizations for GMOs.
  

“This process, known as Comitology, has been broken for years because it allows politics to undermine the risk assessment function of the European Food Safety Authority (EFSA) and other independent European risk assessment agencies. However, with this proposal the Commission is attempting to shift responsibilities back to the Member States rather than working towards building confidence and consensus in support of the independent scientific opinions of EFSA. 
 

“This proposal adds substantial uncertainty regarding the future of EU import approvals for GMO crops and the ability of Europe’s food chain to have access to a reliable and safe supply of high quality imported grains and oilseeds.  Further, this move sends yet another message that Europe has no interest in encouraging investment and innovation in agricultural technologies.”  

Discover More
WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO)  released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…